OCGN Q1 2025 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena

OCGNOcugen, Inc.

$578M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M+46.1% YoY

Gross Profit

$1M100.0% margin

Operating Income

-$15M-979.1% margin

Net Income

-$15M-1036.5% margin

EPS (Diluted)

$-0.05

QoQ Revenue Growth

+93.8%

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$19M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$64M

Total Liabilities

$49M

Stockholders' Equity

$16M

Cash & Equivalents

$38M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$1M	+46.1%
Gross Profit	$1M	$1M	+46.1%
Operating Income	-$15M	-$12M	-18.7%
Net Income	-$15M	-$12M	-28.7%